Works matching IS 15330028 AND DT 2013 AND VI 12 AND IP 3
Results: 10
Treatment Rationale and Study Design for a Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating Onartuzumab (MetMAb) in Combination With Bevacizumab Plus mFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 218, doi. 10.1016/j.clcc.2013.04.001
- By:
- Publication type:
- Article
Discordance of KRAS Mutational Status in a Single Colonic Resection Specimen in a Patient With Colorectal Cancer: A Case Report and Review of the Literature.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 214, doi. 10.1016/j.clcc.2013.04.003
- By:
- Publication type:
- Article
Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 204, doi. 10.1016/j.clcc.2012.11.004
- By:
- Publication type:
- Article
Comparison of KRAS Genotype: Therascreen Assay vs. LNA-Mediated qPCR Clamping Assay.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 195, doi. 10.1016/j.clcc.2013.05.001
- By:
- Publication type:
- Article
Adjuvant Systemic Chemotherapy After Putative Curative Resection of Colorectal Liver and Lung Metastases.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 188, doi. 10.1016/j.clcc.2013.04.002
- By:
- Publication type:
- Article
The Predictive and Prognostic Value of Sex in Early-Stage Colon Cancer: A Pooled Analysis of 33,345 Patients from the ACCENT Database.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 179, doi. 10.1016/j.clcc.2013.04.004
- By:
- Publication type:
- Article
Clinical Utility of KRAS and BRAF Mutations in a Cohort of Patients With Colorectal Neoplasms Submitted for Microsatellite Instability Testing.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 168, doi. 10.1016/j.clcc.2013.04.005
- By:
- Publication type:
- Article
Incidence of Chemotherapy-Induced Amenorrhea in Premenopausal Women Treated With Adjuvant FOLFOX for Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 163, doi. 10.1016/j.clcc.2013.04.007
- By:
- Publication type:
- Article
Adenovirus-Mediated Transcriptional Targeting of Colorectal Cancer and Effects on Treatment-Resistant Hypoxic Cells.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 152, doi. 10.1016/j.clcc.2012.11.005
- By:
- Publication type:
- Article
FOLFIRI-Bevacizumab As First-Line Chemotherapy in 3500 Patients With Advanced Colorectal Cancer: A Pooled Analysis of 29 Published Trials.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 145, doi. 10.1016/j.clcc.2013.04.006
- By:
- Publication type:
- Article